Shionogi Files Oral COVID Antiviral In Japan, Vaccine Shows Phase III Promise

Once-Daily Dosing Option

 
• By Lisa Takagi
Tokyo skyline and Mountain Fuji in Japan
Progress in Japan For Shionogi's oral antiviral and vaccine for COVID-19 • Source: Shutterstock

More from Japan

More from Focus On Asia